Drug Device Combination Products | Episode 01- What are the Regulations for Combination Products?
Welcome to the PharmaCamp with Neha. This is a small initiative from my side to share knowledge about the pharmaceutical world and regulatory, as I feel education is the best gift one can receive or give back to society. Are you a working professional who wants to upgrade your skills? OR a student who wants to make a career in pharmaceuticals? OR are you a person who is interested to learn about the regulatory systems? Then this YouTube channel is for you. About me: I am Neha Parashar, working as a Associate Director in a pharmaceutical company and based in Germany. I am a passionate healthcare professional, an educator, and a mentor. In this series 'Drug Device Combination Products', I will discuss the regaulatory aspects related to Combination products. Channel Introduction- Welcome to PharmaCamp • Welcome to PharmaCamp with Neha | Regulato... Series 1 -Regulatory Learnings | Investigational New Drug (IND) Application • Regulatory Learnings | Investigational New... Series 2-Regulatory Shorts • Regulatory Shorts Series 3-EU Marketing Authorisation • EU Marketing Authorisation Series 4-Dare to Lead with Neha | An Interview Series with Pharma Leaders • Dare To Lead - An Interview Series With Ph... Series 5-Orphan Drug Development • Orphan Drug Development LinkedIn: / neha-parashar LinkedIn Articles on various Regulatory Topics: 1. Regulatory Pathways for Expedited Access of Medicines / regula. . 2. Step-wise Regulatory approach for the Paediatric drug Development / step-w. . 3. Designing the Global Regulatory Strategy for the Development of Orphan Medicinal Products / design. . 4. Step wise approach for Quality Risk Management (QRM) in pharmaceutical industries / step-w. . 5. Step-wise regulatory approach for the assessment of process related impurities in biological products / step-w. . 6. Step-wise approach for sterilisation package preparation in regulatory dossiers for biologicals and other liquid sterilised products / step-w. . 7. Step-wise approach for regulatory risk assessment of adventitious agents in biologicals products / step-w. . 8. Five Step Approach to Assess Equivalency Requirements of Topical Products / five-s. . Disclaimer- This video channel is for educational purposes. These are purely my views and not any recommendations. The channel does not represent the views of the organization I am associated with, and it has no connection with my current organization.

Drug Device Combination Products | Episode 02 - Regulatory Procedure for Combination Products in USA

Why Drugs Are So Expensive

UCL Virtual Open Events 2026: Drug Discovery MSc Courses

Understanding the US FDA Drug Approval Process | Step-by-Step Explanation for Pharma Professionals

How To Think SO CLEARLY People Assume You're A Genius

H1B Visa New Bill 2026: 2-Year Limit, No OPT, No Green Card Path Explained

Why you need ISO 13485 for your medical device manufacturing project

Discover Aseptic Fill-Finish – A Critical Step in Parenteral Manufacturing

Doctor reveals undisclosed risks of COVID-19 vaccine

Drug Device Combination Products | Episode 03-Regulatory Procedure:Combination Products in EU Part-1

What are the Steps and Timelines for Decentralised Procedure and Mutual Recognition Procedure?| DRA

Stop Rambling: The 3-2-1 Speaking Trick That Makes You Sound Like A CEO

Scammers PANIC After I Tell Them Their REAL Names

Marokko – Haiti Highlights | Gruppe C, FIFA WM 2026 | sportstudio

India's Pharmaceutical Success

The 5 most important steps to CE certification - The EU medical device approval process

Drug Device Combination Products | Episode 04-Regulatory Procedure:Combination Products in EU Part-2

Bayer: Wie man einen Traditionskonzern ruiniert

How to Focus to Change Your Brain | Huberman Lab Essentials

